Regeneron executive disposes of 4,229 shares at $701.51

Regeneron Pharmaceuticals, Inc. reported an insider stock transaction by an officer serving as EVP Research.

Rhea-AI Filing Summary

Regeneron Pharmaceuticals, Inc. reported an insider stock transaction by an officer serving as EVP Research. On 12/09/2025, the executive disposed of 4,229 shares of common stock at $701.51 per share in a transaction coded "F".

Following this activity, the officer beneficially owned 47,833 shares of Regeneron common stock directly and 4,375 shares indirectly through a 401(k) plan.

Insider Trade Summary

Exercise Price or Tax Liability: 4,229 shares

Exercise Price or Tax Liability 2 txns

Insider MURPHY ANDREW J

Role EVP Research

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	4,229	$701.51	$2.97M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 47,833 shares (Direct); Common Stock — 4,375 shares (Indirect, By 401(k) Plan)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Regeneron (REGN) report on 12/09/2025?

An officer of Regeneron Pharmaceuticals, Inc. serving as EVP Research reported disposing of 4,229 shares of Regeneron common stock on 12/09/2025.

How many Regeneron (REGN) shares did the EVP Research dispose of and at what price?

The EVP Research disposed of 4,229 shares of Regeneron common stock at a price of $701.51 per share in a transaction coded "F".

How many Regeneron (REGN) shares does the executive beneficially own after the reported transaction?

After the transaction, the executive beneficially owned 47,833 shares of Regeneron common stock directly and 4,375 shares indirectly through a 401(k) plan.

What is the reporting person’s relationship to Regeneron (REGN)?

The reporting person is an officer of Regeneron Pharmaceuticals, Inc., serving in the role of EVP Research, rather than a director or 10% owner.

Was this Regeneron (REGN) insider filing submitted by one or multiple reporting persons?

The filing was indicated as a Form filed by One Reporting Person, not a joint filing by multiple insiders.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/11/2025 - 04:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MURPHY ANDREW J

(Last) (First) (Middle)

777 OLD SAW MILL RIVER ROAD

(Street)

TARRYTOWN NY 10591

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
REGENERON PHARMACEUTICALS, INC. [ REGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP Research

3. Date of Earliest Transaction (Month/Day/Year)
12/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/09/2025		F		4,229	D	$701.51	47,833	D
Common Stock								4,375	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Andrew Murphy	12/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.